Inventor · disambiguated record
Naing Aay
Also filed as: AAY NAING · AAY NAING N
19 granted patents·14 pending applications·150 citations·filing 2006–2025
94Inventor score
Top patents by PatentIndex Score
33 records- 0196US7803839B2Azetidines as MEK inhibitors for the treatment of proliferative diseasesEXELIXIS INC·Filed 2006·Granted Sep 28, 2010·46 cites·68 claims
- 0294US11690915B2Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2021·Granted Jul 4, 2023·9 cites·2 claims
- 0394US11168102B1Bicyclic heteroaryl compounds and uses thereofREVOLUTION MEDICINES INC·Filed 2020·Granted Nov 9, 2021·5 cites·18 claims
- 0494US10590090B22,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitorsREVOLUTION MEDICINES INC·Filed 2018·Granted Mar 17, 2020·28 cites·50 claims
- 0594US7915250B2Azetidines as MEK inhibitors for the treatment of proliferative diseasesEXELIXIS INC·Filed 2010·Granted Mar 29, 2011·22 cites·26 claims
- 0691US8362002B2Azetidines as MEK inhibitors for the treatment of proliferative diseasesEXELIXIS INC·Filed 2011·Granted Jan 29, 2013·12 cites·63 claims
- 0789US2025100966A1Mek inhibitors and methods of their useEXELIXIS INC·Filed 2024·Application pending·0 cites
- 0882US8242129B26-phenylpyrimidinones as PIM modulatorsTSUHAKO AMY L·Filed 2008·Granted Aug 14, 2012·8 cites·12 claims
- 0979US8440663B24-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as JAK-2 modulators and methods of useMANN GRACE·Filed 2007·Granted May 14, 2013·7 cites·33 claims
- 1079US8324231B2Pyrimidinones as casein kinase II (CK2) modulatorsKOLTUN ELENA S·Filed 2008·Granted Dec 4, 2012·5 cites·10 claims
- 1177US11673896B2Pyridine compounds as allosteric SHP2 inhibitorsREVOLUTION MEDICINES INC·Filed 2019·Granted Jun 13, 2023·1 cites·16 claims
- 1275US11739093B2Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as allosteric SHP2 inhibitorsREVOLUTION MEDICINES INC·Filed 2019·Granted Aug 29, 2023·1 cites·18 claims
- 1375US2023374035A1Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2023·Application pending·0 cites
- 1474US11597699B2MEK inhibitors and methods of their useEXELIXIS INC·Filed 2020·Granted Mar 7, 2023·0 cites·1 claims
- 1573US12258366B2Bicyclic heteroaryl compounds and uses thereofREVOLUTION MEDICINES INC·Filed 2022·Granted Mar 25, 2025·0 cites·14 claims
- 1673US8637499B2Benzoxazepines as inhibitors of PI3K/mTOR and methods of their use and manufactureAAY NAING·Filed 2010·Granted Jan 28, 2014·5 cites·23 claims
- 1771US12365688B2Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as allosteric SHP2 inhibitorsREVOLUTION MEDICINES INC·Filed 2023·Granted Jul 22, 2025·0 cites·36 claims
- 1870US2024067636A1Pyridine, pyrazine, and triazine compounds as allosteric shp2 inhibitorsREVOLUTION MEDICINES INC·Filed 2023·Application pending·0 cites
- 1970US2020031770A1Mek inhibitors and methods of their useEXELIXIS INC·Filed 2019·Application pending·0 cites
- 2070US2024101577A1Polycyclic compounds as allosteric shp2 inhibitorsREVOLUTION MEDICINES INC·Filed 2023·Application pending·0 cites
- 2170US2024092795A1Pyridine compounds as allosteric shp2 inhibitorsREVOLUTION MEDICINES INC·Filed 2023·Application pending·0 cites
- 2269US8012956B2Tropane compoundsEXELIXIS INC·Filed 2008·Granted Sep 6, 2011·1 cites·18 claims
- 2369US2025368661A1Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2025·Application pending·0 cites
- 2466US11702411B2Pyridine, pyrazine, and triazine compounds as allosteric SHP2 inhibitorsREVOLUTION MEDICINES INC·Filed 2020·Granted Jul 18, 2023·0 cites·6 claims
- 2566US2019144382A1MEK Inhibitors and Methods of Their UseEXELIXIS INC·Filed 2018·Application pending·0 cites
- 2664US2014275527A1Azetidines as MEK Inhibitors for the Treatment of Proliferative DiseasesEXELIXIS INC·Filed 2013·Application pending·0 cites
- 2764US2021139517A1Bicyclic heteroaryl compounds and uses thereofREVOLUTION MEDICINES INC·Filed 2020·Application pending·0 cites
- 2861US11661401B22,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitorsREVOLUTION MEDICINES INC·Filed 2020·Granted May 30, 2023·0 cites·11 claims
- 2961US2025388598A1Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2025·Application pending·0 cites
- 3060US11673901B2Polycyclic compounds as allosteric SHP2 inhibitorsREVOLUTION MEDICINES INC·Filed 2020·Granted Jun 13, 2023·0 cites·19 claims
- 3157US2017166523A9MEK Inhibitors And Methods Of Their UseEXELIXIS INC·Filed 2015·Application pending·0 cites
- 3248US2023096028A1Bicyclic heterocyclyl compounds and uses thereofREVOLUTION MEDICINES INC·Filed 2020·Application pending·0 cites
- 3347US2023148450A9Bicyclic heteroaryl compounds and uses thereofREVOLUTION MEDICINES INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Naing Aay files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →